Company: ZCARW
Filing Date: 2025-03-28
Form Type: DRS
Source: 0001013762-25-003498
Chunk: 254

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-03-28
Form: DRS
Chunk 254
---
 to new investors by approximately $ ,assuming
the number of units offered remains unchanged and after deducting underwriting discounts, commissions, and estimated offering expenses
payable by us.

An increase or decrease of
1,000,000 units in the number of units offered at the assumed public offering price of $ per
Unit would correspondingly increase or decrease the pro forma, as adjusted net tangible book value per share by $
and the dilution in pro forma, as adjusted net tangible book value per share to new investors by approximately $
, assuming the offering price remains unchanged and after deducting underwriting discounts, commissions, and estimated offering expenses.

The table and information
above assume that the underwriters do not exercise their option to purchase additional common shares (or Pre-Funded Warrants). If the
underwriters fully exercise their option to purchase an additional units, the pro forma, as adjusted net tangible book value per share
after the offering would increase to $ , and the dilution in pro forma, as adjusted net tangible
book value per share to new investors would decrease to approximately $ , assuming the offering
price remains unchanged and after deducting underwriting discounts, commissions, and estimated offering expenses.

The above discussion is based
on [ ] common shares issued and outstanding as of December 31, 2024, and excludes, as of
that date, the following:

The discussion above also
assumes no exercise of the over-allotment option and no sale of Pre-Funded Warrants, which, if sold, would reduce the number of common
shares that we are offering on a one-for-one basis.

To the extent that convertible
and exercisable securities discussed above have been or may be converted or exercised or we issue other common shares or securities convertible
or exercisable into common shares, investors purchasing securities in this offering may experience further dilution. In addition, we may
seek to raise additional capital in the future through the sale of equity or convertible debt securities. To the extent we raise additional
capital through the sale of equity or convertible debt securities, the issuance of such securities could result in further dilution to
our shareholders.

<div align='center'>147

Description of OUR SECURITIES</div>

The following summary of
the material terms of our securities and is not intended to be a complete summary of the rights and preferences of such securities. We
urge you to read our Charter and Bylaws in their entirety for a complete description of the rights and preferences of our securities.

General

Our authorized capital